Milind Deshpande

2008

In 2008, Milind Deshpande earned a total compensation of $410.3K as President, Research and Development and Chief Scientific Officer at Achillion Pharmaceuticals, a 22% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$51,975
Option Awards$61,357
Salary$288,000
Other$8,921
Total$410,253

Deshpande received $288K in salary, accounting for 70% of the total pay in 2008.

Deshpande also received $52K in non-equity incentive plan, $61.4K in option awards and $8.9K in other compensation.

Rankings

In 2008, Milind Deshpande's compensation ranked 7,089th out of 9,135 executives tracked by ExecPay. In other words, Deshpande earned more than 22.4% of executives.

ClassificationRankingPercentile
All
7,089
out of 9,135
22nd
Division
Manufacturing
2,651
out of 3,436
23rd
Major group
Chemicals And Allied Products
599
out of 815
27th
Industry group
Drugs
423
out of 597
29th
Industry
Pharmaceutical Preparations
304
out of 408
26th
Source: SEC filing on April 19, 2011.

Deshpande's colleagues

We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2008.

2008

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2008

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2008

Gautam Shah

Achillion Pharmaceuticals

Senior Vice President and Chief Compliance Officer

2008

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

News

You may also like